Terms: = Endocrine gland cancer AND RAP1GDS1, P52306, 5910, MGC118861, MGC118859, GDS1, ENSG00000138698 AND Treatment
3 results:
1. Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer.
Nissim S; Leshchiner I; Mancias JD; Greenblatt MB; Maertens O; Cassa CA; Rosenfeld JA; Cox AG; Hedgepeth J; Wucherpfennig JI; Kim AJ; Henderson JE; Gonyo P; Brandt A; Lorimer E; Unger B; Prokop JW; Heidel JR; Wang XX; Ukaegbu CI; Jennings BC; Paulo JA; Gableske S; Fierke CA; Getz G; Sunyaev SR; Wade Harper J; Cichowski K; Kimmelman AC; Houvras Y; Syngal S; Williams C; Goessling W
Nat Genet; 2019 Sep; 51(9):1308-1314. PubMed ID: 31406347
[TBL] [Abstract] [Full Text] [Related]
2. A meta-analysis of bevacizumab combined with chemotherapy in the treatment of ovarian cancer.
Wang TS; Lei W; Cui W; Wen P; Guo HF; Ding SG; Yang YP; Xu YQ; Lv SW; Zhu YL
Indian J Cancer; 2014 Mar; 51 Suppl 3():e95-8. PubMed ID: 25818743
[TBL] [Abstract] [Full Text] [Related]
3. Granulosa cell tumors of the ovary: prognostic factors and outcome.
Malmström H; Högberg T; Risberg B; Simonsen E
Gynecol Oncol; 1994 Jan; 52(1):50-5. PubMed ID: 8307501
[TBL] [Abstract] [Full Text] [Related]
